Inclusion Criteria:  patient ≥ 18 years old, symptomatic COVID-19 for less than 96 hours (see list of symptoms in appendix), tested positive for SARS-CoV-2 by RT-PCR on a nasopharyngeal sample within 48 hours of inclusion, following an effective method of contraception for women of childbearing age, affiliated to a social security scheme, informed and written consent from patient.  Exclusion Criteria:  patient requiring normal hospitalization or intensive care oxygen-requiring patient, with a history of parasitosis, in particular filariasis, with a history of hypereosinophilia, notion of recent travel (less than 3 months) in poor hygienic conditions taking ivermectin in the last 12 months, contraindications to ivermectin or one of the constituents of the drug (known history of allergies), pregnant or breastfeeding women, participation in another interventional study relating to COVID-19 concerning a drug during this research, patient under AME or without social security coverage.